Perrigo Company (PRGO) financial statements (2021 and earlier)

Company profile

Business Address THE SHARP BUILDING
DUBLIN 2, D02 TY74
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments642354551679622798805
Cash and cash equivalents642354551679622786800
Short-term investments     136
Receivables1,0541,2431,0731,1311,1761,282935
Inventory, net of allowances, customer advances and progress billings1,200967878807795839632
Inventory1,200967878807795839632
Other undisclosed current assets238192400203212264179
Total current assets:3,1342,7572,9022,8202,8053,1832,551
Noncurrent Assets
Operating lease, right-of-use asset186130
Property, plant and equipment996903829833870932780
Intangible assets, net (including goodwill)    8,58116,39610,938
Goodwill    4,0494,9723,474
Intangible assets, net (excluding goodwill)    4,53211,4247,464
Deferred income tax assets445
Other noncurrent assets371400363410212225195
Deferred tax assets, net  724024
Other undisclosed noncurrent assets6,7587,1076,8897,5671,330(1,055)(607)
Total noncurrent assets:8,3558,5458,0818,80911,06516,53811,329
TOTAL ASSETS:11,48811,30110,98311,62913,87019,72113,880
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9789389059468831,180673
Accounts payable544520475450472748364
Accrued liabilities250229201231263246179
Employee-related liabilities175156132149116134112
Taxes payable93297116325317
Debt3831907057365144
Deferred tax liabilities   811
Other undisclosed current liabilities366394442420380368257
Total current liabilities:1,3821,3361,5371,4361,8361,6941,075
Noncurrent Liabilities
Long-term debt and lease obligation3,5283,3663,0523,2715,2255,2473,091
Long-term debt, excluding current maturities3,5283,3663,0523,2715,2255,2473,091
Liabilities, other than long-term debt9237964434308522,1171,021
Deferred tax liabilities, net  3901,745728
Deferred income tax liabilities279281
Other liabilities644515443430462372293
Other undisclosed noncurrent liabilities  282322   
Total noncurrent liabilities:4,4514,1623,7784,0226,0767,3644,112
Total liabilities:5,8335,4975,3155,4587,9139,0585,187
Stockholders' equity
Stockholders' equity attributable to parent5,6555,8045,6686,1715,95810,6638,693
Common stock7,1187,3607,4227,8938,1358,6226,678
Accumulated other comprehensive income (loss)39513985253(82)102140
Retained earnings (accumulated deficit)(1,858)(1,696)(1,838)(1,976)(2,095)1,9381,875
Stockholders' equity attributable to noncontrolling interest 000(1)01
Total stockholders' equity:5,6555,8045,6686,1715,95810,6638,694
TOTAL LIABILITIES AND EQUITY:11,48811,30110,98311,62913,87019,72113,880

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
6/30/2014
Revenues5,0634,8374,7324,9465,2814,6044,061
Revenue, net4,9465,2814,6044,061
Cost of revenue
(Cost of Goods and Services Sold)
(3,248)(3,064)(2,900)(2,967)(3,229)(2,891)(2,613)
Gross profit:1,8151,7731,8321,9802,0521,7131,448
Operating expenses(1,700)(1,569)(1,595)(1,381)(4,052)(965)(1,178)
Other operating expense, net
(Other Expenses)
     (343) 
Other undisclosed operating income     343298
Operating income (loss):115205237598(2,000)748567
Nonoperating income (expense)(17)66(6)10(24) (12)
Other nonoperating income (expense)(17)66(6)10(23) (12)
Interest and debt expense(20)(0)(1)(135)(1)(11)(166)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  61  (489)(116)
Income (loss) from continuing operations before equity method investments, income taxes:78271291473(2,024)248273
Income (loss) from equity method investments   0(4)(10) 
Income (loss) from continuing operations before income taxes:78271291473(2,028)238273
Income tax expense (benefit)(13)(25)(160)(161)836(120)(67)
Net income (loss):65246131313(1,193)118205
Other undisclosed net income (loss) attributable to parent(228)(100) (193)(2,820)10 
Net income (loss) available to common stockholders, diluted:(163)146131120(4,013)128205

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
6/30/2014
Net income (loss):65246131313(1,193)118205
Other comprehensive income (loss)   (1)(67)(37)63
Comprehensive income (loss):65246131312(1,259)81268
Other undisclosed comprehensive income (loss), net of tax, attributable to parent28(45)(168)142(2,820)10 
Comprehensive income (loss), net of tax, attributable to parent:93201(37)455(4,079)91268

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: